About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Early Immunotherapy Better in Stomach Cancer If Combined With Chemo

by Angela Mohan on November 6, 2020 at 2:54 PM
Font : A-A+

Early Immunotherapy Better in Stomach Cancer If Combined With Chemo

Immunotherapy may work better if the therapy is delivered earlier in combination with standard chemotherapy, says a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons, in mice, published in the journal Gastroenterology.

"Patients with advanced stomach cancer have limited treatment options," says Woosook Kim, PhD, first author of the paper who was an associate research scientist at Columbia when the study was done.

Advertisement


"Many are not eligible for surgical resection, and response to radiotherapy or chemotherapy is often low."

Many cancer cells have proteins that prevent our immune cells from attacking the tumor. Immunotherapies block these proteins, thereby unleashing the immune cells.
Advertisement

The Columbia researchers looked closely at the microenvironment around the tumors in mice that develop this disease. Mice with more advanced disease had an abundance of myeloid-derived suppressor cells (MDSCs) that also express PDL1 proteins, which appear to overpower the immunotherapy.

When immunotherapy was given to mice with these advanced tumors, the cancer was unaffected. Only when immunotherapy was given to the mice early, before tumors formed and prior to the accumulation of MDSCs, could cancer progression be slowed.

Combining immunotherapy with standard chemotherapy also shrank larger stomach tumors, because the chemotherapy killed many of the MDSCs.

"Our study suggests that adding chemotherapy to immunotherapy may improve responsiveness in part through the targeting of MDSCs," says Timothy Wang, MD, the Dorothy L. and Daniel H. Silberberg Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons and study leader.

"While we do not have enough information to determine if the level of MDSCs may predict response to this dual regimen, our findings show that administering immunotherapy in combination with chemotherapy earlier in the course of the disease, when MDSC levels are much lower, may boost response rates in stomach cancer," says Wang.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Gastroscopy Gastric Cancer Cancer and Homeopathy Immunisation Cancer Facts Cancer Tattoos A Body Art Peritoneal Cancer Dealing with Pollen Allergy Common Lifestyle Habits that Cause Diseases 

Most Popular on Medindia

Post-Nasal Drip Sinopril (2mg) (Lacidipine) Vent Forte (Theophylline) Hearing Loss Calculator Loram (2 mg) (Lorazepam) Color Blindness Calculator Accident and Trauma Care Find a Hospital Sanatogen Selfie Addiction Calculator

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use